The U.S. Food and Drug Administration (FDA) recently approved the use of Darzalex Faspro (daratumumab and hyaluronidase-fihj) ...

Prolonged diagnostic latency can follow vague fatigue, back pain, and breathing issues, reinforcing the need for persistent ...

Hope is positioned as an organizing principle for coping with post-treatment emotional distress, including isolation, ...

During an interview with CURE, Chris Draft, founder of Team Draft, discussed how patients with cancer can begin to feel more in control and even step into advocacy after receiving ...

Experts have highlighted the potential of irpagratinib to become the first truly precision-targeted therapy for liver cancer. With FDA fast track designation now in place, Abbisko Therapeutics plans ...

Colleen Mabasa shared her experience navigating CAR-T cell therapy beyond the clinical aspects of treatment. Colleen Mabasa, a patient advocate with multiple myeloma, sat down with CURE for an ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

Curtis Pesmen | Authors | CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

CURE spoke with Dr. Kathie-Ann Joseph about the importance of personalized, multidisciplinary treatments when caring for ...

For many patients, the path to a liver cancer diagnosis is not straightforward. Symptoms can be vague, tests inconclusive and ...

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

Mary Royal, a 54-year-old mother of four, received a diagnosis of multicentric breast cancer in 2023, a diagnosis which ...